Cargando…

Angiopoietins as Potential Targets in Management of Retinal Disease

The Ang/Tie2 pathway complements VEGF-mediated activity in retinal vascular diseases such as DME, AMD, and RVO by decreasing vascular integrity, increasing neovascularization, and increasing inflammatory signaling. Faricimab is a bispecific antibody that has been developed as an inhibitor of both VE...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khanani, Arshad M, Russell, Matthew W, Aziz, Aamir A, Danzig, Carl J, Weng, Christina Y, Eichenbaum, David A, Singh, Rishi P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427682/ https://www.ncbi.nlm.nih.gov/pubmed/34511878 http://dx.doi.org/10.2147/OPTH.S231801

Ejemplares similares

Targeting Angiopoietin in Retinal Vascular Diseases: A Literature Review and Summary of Clinical Trials Involving Faricimab
por: Khan, Majid, et al.
Publicado: (2020)

Emerging Treatment Options for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration
por: Khan, Hannah, et al.
Publicado: (2023)

OPTIMAL MANAGEMENT OF PIGMENT EPITHELIAL DETACHMENTS IN EYES WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
por: Khanani, Arshad M., et al.
Publicado: (2018)

Anti-angiogenic Targets: Angiopoietin and Angiopoietin Receptors
por: Kiss, Elina A., et al.
Publicado: (2019)

Cooling Anesthesia for Intravitreal Injections – A Review
por: Chandrasekaran, Priya R, et al.
Publicado: (2023)

Emerging Therapies in Neovascular Age-Related Macular Degeneration in 2020
por: Samanta, Anindya, et al.
Publicado: (2020)

Targeting the Angiopoietin/Tie Pathway: Prospects for Treatment of Retinal and Respiratory Disorders
por: Akwii, Racheal Grace, et al.
Publicado: (2021)

RETINAL FLUID AND THICKNESS AS MEASURES OF DISEASE ACTIVITY IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
por: Kaiser, Peter K., et al.
Publicado: (2021)

The Role of Angiopoietins in Neovascular Diabetes-Related Retinal Diseases
por: Collazos-Alemán, Juan David, et al.
Publicado: (2022)

In Uveal Melanoma, Angiopoietin-2 but Not Angiopoietin-1 Is Increased in High-Risk Tumors, Providing a Potential Druggable Target
por: ten Voorde, Anna M.W., et al.
Publicado: (2021)

IMPACT OF RETINAL FLUID-FREE MONTHS ON OUTCOMES IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A Treatment Agnostic Analysis of the HAWK and HARRIER Studies
por: Eichenbaum, David, et al.
Publicado: (2023)

The Role of Angiopoietins as Potential Therapeutic Targets in Renal Cell Carcinoma()
por: Wang, Xiaoen, et al.
Publicado: (2014)

Angiopoietin-2 and Angiopoietin-2/Angiopoietin-1 Ratio as Indicators of Potential Severity of Plasmodium vivax Malaria in Patients with Thrombocytopenia
por: Gomes, Luciano Teixeira, et al.
Publicado: (2014)

Correction: Angiopoietin-2 and Angiopoietin-2/Angiopoietin-1 Ratio as Indicators of Potential Severity of Plasmodium vivax Malaria in Patients with Thrombocytopenia
Publicado: (2015)

Pericyte Insulin Receptors Modulate Retinal Vascular Remodeling and Endothelial Angiopoietin Signaling
por: Warmke, Nele, et al.
Publicado: (2021)

Association of serum angiopoietin-1, angiopoietin-2 and angiopoietin-2 to angiopoietin-1 ratio with heart failure in patients with acute myocardial infarction
por: CHEN, SHAOMIN, et al.
Publicado: (2013)

Systematic review of the role of angiopoietin-1 and angiopoietin-2 in Plasmodium species infections: biomarkers or therapeutic targets?
por: de Jong, Gerdie M., et al.
Publicado: (2016)

Aflibercept Suppression of Angiopoietin-2 in a Rabbit Retinal Vascular Hyperpermeability Model
por: Lange, Claudia, et al.
Publicado: (2023)

Aflibercept Suppression of Angiopoietin-2 in a Rabbit Retinal Vascular Hyperpermeability Model
por: Lange, Claudia, et al.
Publicado: (2023)

Quantifying burden of intravitreal injections: questionnaire assessment of life impact of treatment by intravitreal injections (QUALITII)
por: Wang, Rui, et al.
Publicado: (2022)

Dynamic Angiopoietin-2 Serum Level as Endothelial Damage Marker and Potential Therapeutic Target
por: Melegari, Gabriele, et al.
Publicado: (2022)

Cooperation of Angiopoietin-2 and Angiopoietin-4 in Schlemm's Canal Maintenance
por: Kapiainen, Emmi, et al.
Publicado: (2022)

The real-world efficacy and safety of faricimab in neovascular age-related macular degeneration: the TRUCKEE study – 6 month results
por: Khanani, Arshad M., et al.
Publicado: (2023)

Purtscher's-like retinopathy associated with acute pancreatitis
por: Gahn, Greggory M., et al.
Publicado: (2020)

Clinical experience with fixed bimonthly aflibercept dosing in treatment-experienced patients with neovascular age-related macular degeneration
por: Khanani, Arshad M
Publicado: (2015)

Angiopoietins in Diabetic Retinopathy: Current Understanding and Therapeutic Potential
por: Whitehead, Michael, et al.
Publicado: (2019)

Prognostic significance of the angiopoietin-2/angiopoietin-1 and angiopoietin-1/Tie-2 ratios for early sepsis in an emergency department
por: Fang, Yingying, et al.
Publicado: (2015)

Angiopoietins and diabetic nephropathy
por: Gnudi, Luigi
Publicado: (2016)

Clinical and prognostic significance of circulating levels of angiopoietin-1 and angiopoietin-2 in hepatocellular carcinoma
por: Pestana, Roberto Carmagnani, et al.
Publicado: (2018)

Delineating effects of angiopoietin-2 inhibition on vascular permeability and inflammation in models of retinal neovascularization and ischemia/reperfusion
por: Canonica, Jérémie, et al.
Publicado: (2023)

Angiopoietin-1, Angiopoietin-2 and Bicarbonate as Diagnostic Biomarkers in Children with Severe Sepsis
por: Wang, Kun, et al.
Publicado: (2014)

Angiopoietin-2, Angiopoietin-1 and subclinical cardiovascular disease in Chronic Kidney Disease
por: Tsai, Yi-Chun, et al.
Publicado: (2016)

Angiopoietin-like 3 inhibition of endothelial lipase is not modulated by angiopoietin-like 8
por: Sylvers-Davie, Kelli L., et al.
Publicado: (2021)

Ratio of Angiopoietin-2 to Angiopoietin-1 predicts mortality in acute lung injury induced by paraquat
por: Choi, Jae-Sung, et al.
Publicado: (2013)

Gains in the current understanding of managing neovascular AMD with brolucizumab
por: Bodaghi, Bahram, et al.
Publicado: (2023)

Expression and function of angiopoietin-1 in breast cancer
por: Hayes, A J, et al.
Publicado: (2000)

Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial
por: Patel, Sunil S., et al.
Publicado: (2023)

Correction: Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial
por: Patel, Sunil S., et al.
Publicado: (2023)

Differential response of lymphatic, venous and arterial endothelial cells to angiopoietin-1 and angiopoietin-2
por: Nguyen, Vicky PKH, et al.
Publicado: (2007)

Angiopoietin-2/angiopoietin-1 as non-invasive biomarker of cirrhosis in chronic hepatitis C
por: Hernández-Bartolomé, Ángel, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_st77bqhco98iuc0jij8k67evpd